Background Australia has provided free quadrivalent human papillomavirus (HPV) vaccines to school girls since mid-2007 and a catch-up programme in the community to women aged up to 26 years in 2007- 2009. We describe the temporal trend of genital warts in different populations in Melbourne. Methods We analysed the proportion diagnosed with genital warts for all new patients attending Melbourne Sexual Health Centre from July 2004 to June 2014, stratified by different risk groups and age. Adjusted ORs were calculated to compare the annual trend in the proportion of patients with genital warts in different risk groups in the prevaccination period (before June 2007) and the vaccination period (after July 2007). Results The proportion with genit...
OBJECTIVES To examine the impact of the national human papillomavirus (HPV) vaccination program (...
Abstract Background Human papillomavirus (HPV) is one of the most common sexually transmitted pathog...
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years commenced in A...
Background: Australia provided free quadrivalent human papillomavirus vaccines to 12-18-year-old gir...
BACKGROUND: There has been a rapid decline in the number of young heterosexuals diagnosed with genit...
Since the introduction of Australia's human papillomavirus vaccination program, the management rate ...
Since the introduction of Australia's human papillomavirus vaccination program, the management rate ...
OBJECTIVES: Since the introduction of Australia's human papillomavirus vaccination program, the mana...
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics ...
OBJECTIVES: Since the introduction of Australia's human papillomavirus vaccination program, the mana...
Background: Human papillomavirus (HPV) vaccination targeting females 12-13 years commenced in Austra...
ABSTRACT: Background: Substantial declines in genital warts have been observed in countries with qua...
Background. More than 90 % of genital warts (GW) cases are caused by human papillomavirus (HPV) type...
Background. More than 90 % of genital warts (GW) cases are caused by human papillomavirus (HPV) type...
Objectives: Australia introduced a nationwide human papillomavirus (HPV) vaccination programme for w...
OBJECTIVES To examine the impact of the national human papillomavirus (HPV) vaccination program (...
Abstract Background Human papillomavirus (HPV) is one of the most common sexually transmitted pathog...
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years commenced in A...
Background: Australia provided free quadrivalent human papillomavirus vaccines to 12-18-year-old gir...
BACKGROUND: There has been a rapid decline in the number of young heterosexuals diagnosed with genit...
Since the introduction of Australia's human papillomavirus vaccination program, the management rate ...
Since the introduction of Australia's human papillomavirus vaccination program, the management rate ...
OBJECTIVES: Since the introduction of Australia's human papillomavirus vaccination program, the mana...
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics ...
OBJECTIVES: Since the introduction of Australia's human papillomavirus vaccination program, the mana...
Background: Human papillomavirus (HPV) vaccination targeting females 12-13 years commenced in Austra...
ABSTRACT: Background: Substantial declines in genital warts have been observed in countries with qua...
Background. More than 90 % of genital warts (GW) cases are caused by human papillomavirus (HPV) type...
Background. More than 90 % of genital warts (GW) cases are caused by human papillomavirus (HPV) type...
Objectives: Australia introduced a nationwide human papillomavirus (HPV) vaccination programme for w...
OBJECTIVES To examine the impact of the national human papillomavirus (HPV) vaccination program (...
Abstract Background Human papillomavirus (HPV) is one of the most common sexually transmitted pathog...
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years commenced in A...